Efficacy of Pea Hull Fiber in Chronic Disease
NCT03354364 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2019-09-25
Summary
The purpose of this study is to determine the effects of daily consumption of snacks with and without pea hull fiber on gastrointestinal function, gastrointestinal symptoms, food intake, appetite, changes in fecal and microbial composition and activity. Fifty maintenance hemodialysis hemodialysis and CKD patients in stage 4 or 5 will be recruited to participate in a randomized, blinded, 13-week cross-over study evaluating snack foods containing 15 g/d of pea hull fiber.
Conditions
- Kidney Disease, Chronic
Interventions
- DIETARY_SUPPLEMENT
-
Pea hull fiber
Snacks containing 15 g/day of ground pea hulls.
- DIETARY_SUPPLEMENT
-
Control
Snacks without added fiber.
Sponsors & Collaborators
-
Saskatchewan Pulse Growers
collaborator OTHER -
University of Florida
lead OTHER
Principal Investigators
-
Wendy J Dahl, PhD · University of Florida
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-11
- Primary Completion
- 2019-06-30
- Completion
- 2019-08-19
Countries
- United States
Study Locations
More Related Trials
-
Pomegranate and Hemodialysis Pilot Trial
NCT01562340 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
NCT03617536 ·Status: COMPLETED ·Phase: PHASE2
-
Gut Microbiome and p-Inulin in CKD - TarGut CKD Study
NCT03348592 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease
NCT01475760 ·Status: COMPLETED ·Phase: NA
-
PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum
NCT01319578 ·Status: COMPLETED ·Phase: NA
-
Renal Impairment Study of PF-06700841
NCT04260464 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
NCT05342623 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
NCT01843790 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function
NCT00596518 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients
NCT00317694 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis
NCT00730145 ·Status: COMPLETED ·Phase: PHASE1
-
Novel PAradigm to Improve Inflammatory Burden in ESRD (rePAIR): A Pilot and Feasibility Randomized Controlled Trial
NCT03241511 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
NCT01660243 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4
NCT04707573 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-finding Study of KHK7791 in Hyperphosphatemia Patients
NCT03864458 ·Status: COMPLETED ·Phase: PHASE2
-
Peginesatide for Anemia in Chronic Hemodialysis Patients
NCT00228449 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients
NCT03325621 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Feasibility, and Tolerability of Sulforaphane in Children with Chronic Kidney Disease
NCT05653492 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus
NCT02671162 ·Status: COMPLETED ·Phase: PHASE2
-
CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
NCT05356403 ·Status: TERMINATED ·Phase: PHASE3
-
Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
NCT05885737 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study
NCT00767221 ·Status: COMPLETED ·Phase: PHASE2
-
Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
NCT00843349 ·Status: COMPLETED ·Phase: NA
-
Chitosan Chewing Gum Study in Dialysis Patients
NCT01770470 ·Status: COMPLETED
-
Pharmacokinetics, Pharmacodynamics and Safety of Basis in Acute Kidney Injury Study
NCT03176628 ·Status: COMPLETED ·Phase: NA